• Mylan Pharma recalls valsartan-containing products from US market

    • December 6, 2018
    • Posted By : admin
    • 0 Comment
    •   66 views

    Mylan said on Tuesday it is issuing a nationwide voluntary recall of all lots of its blood pressure medicine valsartan, expanding a recall of select batches initiated two weeks ago.

    The drugmaker said it was recalling 104 additional lots “out of an abundance of caution” after the valsartan-containing products were found to contain traces of a probable cancer-causing impurity.

    The finished products, which were manufactured by Mylan Pharmaceuticals and Mylan Laboratories were distributed in the United States between March 2017 and November 2018, the company said in a statement.

    Shares of the company fell 2 percent to $33.40 after the announcement.

  66 views

You Might Also Like

No comments found

LEAVE COMMENT

Archive

Offers
error: Content is protected !!